KEAP1 and cancer: Based on studies demonstrating that sole overexpression of NRF2 in normal cells does not cause carcinogenesis, it is clear that constitutive activation of NRF2 by KEAP1 or NRF2 mutations, which are often encountered in NRF2-activated cancers, is not by itself cancer driver40–42.